4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with transforming growth factor beta in 1 studies
| Studies (4-benzyl-3-crotonyl-2-oxazolidinone) | Trials (4-benzyl-3-crotonyl-2-oxazolidinone) | Recent Studies (post-2010) (4-benzyl-3-crotonyl-2-oxazolidinone) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 13 | 0 | 9 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Ma, J; Qiu, Y; Wang, M; Zhang, M; Zhao, X | 1 |
1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and transforming growth factor beta
| Article | Year |
|---|---|
Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
Topics: Actins; Animals; Carbon Tetrachloride; Cell Movement; Collagen Type I; Collagen Type II; E-Selectin; Hepatic Stellate Cells; Hydroxyproline; Liver Cirrhosis; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Oxazolidinones; Peroxidase; Phosphatidylethanolamine Binding Protein; Platelet-Derived Growth Factor; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 2019 |